Letter of response regarding adrenal SABR to the article published in the March 2024 journal publication: Prospective longitudinal assessment of quality of life after stereotactic ablative radiotherapy for oligometastases: Analysis of the population-based SABR-5 phase II trial by Cruz-Lim et al.
Irwin, A Clarke, H Ghafoor, Q Watkins, S
Irwin, A
Clarke, H
Ghafoor, Q
Watkins, S
Citations
Altmetric:
Affiliation
UHB
Other Contributors
Publication date
2024-04-20
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available.
Citation
Irwin A, Clarke H, Ghafoor Q, Watkins S. Letter of Response Regarding Adrenal SABR to the Article Published in the March 2024 Journal Publication: Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial by Cruz-Lim et al. Clin Oncol (R Coll Radiol). 2024 Jul;36(7):e239. doi: 10.1016/j.clon.2024.04.005. Epub 2024 Apr 20.
Type
Other